Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Acute Myeloid Leukemia(AML)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05457010
What this trial is testing

Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Arcellx, Inc. 24
Early research (Phase 1)Study completedNCT00003962
What this trial is testing

Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Ended earlyNCT03735446
What this trial is testing

Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Dana-Farber Cancer Institute 2
Early research (Phase 1)Ended earlyNCT04021368
What this trial is testing

RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaHigh-risk Myelodysplastic Syndrome
Ryvu Therapeutics SA 51
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Early research (Phase 1)Study completedNCT01768897
What this trial is testing

CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+4 more
Wake Forest University Health Sciences 67
Testing effectiveness (Phase 2)WithdrawnNCT02829840
What this trial is testing

Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML)

Who this might be right for
LeukemiaFLT3-Mutated Acute Myeloid LeukemiaFLT3-Mutated High-Risk Myelodysplastic Syndrome
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT00101140
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

Who this might be right for
Adult Acute Erythroid LeukemiaAdult Acute Monoblastic and Acute Monocytic LeukemiaAdult Acute Myeloid Leukemia
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT05884333
What this trial is testing

Cord Blood Transplant in Adults With Blood Cancers

Who this might be right for
Acute Myelogenous Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)Chronic Myelogenous Leukemia (CML)+3 more
Memorial Sloan Kettering Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT02196857
What this trial is testing

Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Looking for participantsNCT04996875
What this trial is testing

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Who this might be right for
Advanced Systemic Mastocytosis (AdvSM)SM With an Associated Hematologic Neoplasm (SM-AHN)Mast Cell Leukemia (MCL)+1 more
Cogent Biosciences, Inc. 140
Not applicableLooking for participantsNCT07183878
What this trial is testing

Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)

Who this might be right for
Acute Myeloid LeukemiaHigh-Risk Acute Myeloid LeukemiaMyelodysplastic Syndromes+1 more
First Affiliated Hospital of Zhejiang University 138
Testing effectiveness (Phase 2)Looking for participantsNCT03214562
What this trial is testing

Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
High Risk Myelodysplastic SyndromeRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
M.D. Anderson Cancer Center 116
Testing effectiveness (Phase 2)UnknownNCT00838240
What this trial is testing

Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
European Organisation for Research and Treatment of Cancer - EORTC 114
Testing effectiveness (Phase 2)Study completedNCT00143559
What this trial is testing

Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies

Who this might be right for
LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+6 more
St. Jude Children's Research Hospital 17
Early research (Phase 1)Ended earlyNCT04477291
What this trial is testing

CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Aptose Biosciences Inc. 45
Large-scale testing (Phase 3)Study completedNCT00454480
What this trial is testing

Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic Syndromes
The University of New South Wales 2,000
Early research (Phase 1)Ended earlyNCT05569512
What this trial is testing

Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML

Who this might be right for
Acute Myeloid LeukemiaPediatric Cancer
Malika Kapadia 1
Early research (Phase 1)Ended earlyNCT05275439
What this trial is testing

Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Shattuck Labs, Inc. 106
Early research (Phase 1)Ended earlyNCT00049582
What this trial is testing

Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+10 more
National Cancer Institute (NCI) 36
Next Page